Stellantis (NYSE:STLA – Get Free Report) saw a significant drop in short interest in November. As of November 30th, there was short interest totalling 15,660,000 shares, a drop of 18.3% from the November 15th total of 19,160,000 shares. Currently, 0.8% of the company’s stock are sold short. Based on an average daily volume of 9,640,000 shares, the days-to-cover ratio is presently 1.6 days.
Stellantis Trading Up 1.8 %
Shares of NYSE STLA traded up $0.24 during mid-day trading on Friday, reaching $13.95. The company’s stock had a trading volume of 9,559,824 shares, compared to its average volume of 7,201,572. The stock has a 50-day moving average of $13.30 and a two-hundred day moving average of $16.33. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.14 and a quick ratio of 0.85. Stellantis has a 1-year low of $12.12 and a 1-year high of $29.51.
Analyst Ratings Changes
Several research analysts have recently issued reports on the company. Royal Bank of Canada restated a “sector perform” rating on shares of Stellantis in a research note on Friday, October 4th. Evercore ISI initiated coverage on shares of Stellantis in a research note on Monday, November 11th. They set an “inline” rating for the company. Barclays lowered shares of Stellantis from an “overweight” rating to an “equal weight” rating in a research note on Thursday, October 3rd. Finally, Wolfe Research restated a “peer perform” rating on shares of Stellantis in a research report on Thursday, September 5th. Eight equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $27.34.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the stock. Canada Pension Plan Investment Board raised its position in Stellantis by 0.4% in the second quarter. Canada Pension Plan Investment Board now owns 9,838,506 shares of the company’s stock valued at $194,755,000 after purchasing an additional 43,159 shares during the period. AustralianSuper Pty Ltd raised its holdings in Stellantis by 26.3% in the 3rd quarter. AustralianSuper Pty Ltd now owns 9,089,415 shares of the company’s stock valued at $125,597,000 after buying an additional 1,894,146 shares during the period. Conifer Management L.L.C. lifted its position in Stellantis by 26.4% in the third quarter. Conifer Management L.L.C. now owns 9,000,000 shares of the company’s stock valued at $126,450,000 after buying an additional 1,880,000 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Stellantis by 19.0% during the second quarter. Dimensional Fund Advisors LP now owns 8,925,189 shares of the company’s stock valued at $177,163,000 after acquiring an additional 1,425,814 shares during the last quarter. Finally, Franklin Resources Inc. raised its stake in shares of Stellantis by 74.7% in the 3rd quarter. Franklin Resources Inc. now owns 7,605,563 shares of the company’s stock valued at $102,340,000 after acquiring an additional 3,252,492 shares during the period. Hedge funds and other institutional investors own 59.48% of the company’s stock.
Stellantis Company Profile
Stellantis N.V. engages in the design, engineering, manufacturing, distribution, and sale of automobiles and light commercial vehicles, engines, transmission systems, metallurgical products, mobility services, and production systems worldwide. It provides luxury and premium vehicles; sport utility vehicles; American and European brand vehicles; and parts and services, as well as retail and dealer financing, leasing, and rental services.
Further Reading
- Five stocks we like better than Stellantis
- How to Invest in Biotech Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is the Shanghai Stock Exchange Composite Index?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Stellantis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stellantis and related companies with MarketBeat.com's FREE daily email newsletter.